JOSEPH LOSCALZO

Profile

First Name

: JOSEPH

Middle Name

:

Last Name

: LOSCALZO

Related Companies

Titles

Company Name

Related People

DIRECTOR

N30 PHARMACEUTICALS, INC.

ROBERT CONWAY, HOWARD FURST, MITCHELL GOLD, ZELANNA GOLDBERG, NATASHA HERNDAY, JONATHAN LEFF, MARK JAMES LITTON, EVAN LOH, JOHN MOORE, CHRISTOPHER PEETZ, STANFORD PENG, JAMES PAUL RICKEY, PAUL SEKHRI, TOM SOKOLOWSKI, PETER THOMPSON, JAMES TOPPER, JAY VENKATESAN, CUI XIANGMIN

DIRECTOR

LEAP THERAPEUTICS, INC.

JAMES CAVANAUGH, THOMAS DIETZ, CHRISTINE GRANFIELD, AUGUSTINE LAWLOR, WILLIAM LI, JOHN LITTLECHILD, PATRICIA MARTIN, NISSIM MASHIACH, CHRISTOPHER MIRABELLI, CHRISTOPHER K. MIRABELLI, MARK O-MAHONY, DOUGLAS ONSI, DOUGLAS E. ONSI, CHRISTIAN RICHARD, RICHARD SCHILSKY, CYNTHIA SIRARD

DIRECTOR

SCIPHER MEDICINE CORP

TIM ANDERSON, ALBERT-LASZLO BARABASI, ALBERT LASZLO BARABSI, INGO CHAKRAVARTY, BYRON KALOGEROU, SAMIR KAUL, MIKLOS KOBOR, ALBERT LASZLO BARABASI, GLENN MUIR, MICHAEL RUBIN, PETER RUPPERT, JEFFREY SACHS, ALIF SALEH, REGINALD SEETO, TODD SONE, MARCELL VEIDNER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-05-02

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2023-01-17

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-03-12

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-03-12

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-05-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-05-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-08-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2018-05-09

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2017-11-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-11-18